Hye can you name antiarrhythmic drugs

Reading File
search_medical_text

antiarrhythmic drugs classification Vaughan Williams mechanism of action

GradeResponse
Here is a comprehensive overview of antiarrhythmic drugs, classified by the Vaughan Williams Classification system:

Antiarrhythmic Drugs — Vaughan Williams Classification


Class I — Sodium Channel Blockers

Block fast Na⁺ channels → slow phase 0 depolarization
SubclassMechanismDrugs
IaModerate Na⁺ block + ↑ APDQuinidine, Procainamide, Disopyramide
IbWeak Na⁺ block + ↓ APDLidocaine, Mexiletine, Phenytoin
IcStrong Na⁺ block, minimal APD changeFlecainide, Propafenone, Encainide

Class II — Beta-Blockers

Block β-adrenergic receptors → ↓ SA node automaticity, ↓ AV node conduction
  • Metoprolol
  • Atenolol
  • Propranolol
  • Esmolol (short-acting, IV)
  • Carvedilol
  • Bisoprolol

Class III — Potassium Channel Blockers

Block K⁺ channels → prolong repolarization and action potential duration (APD)
  • Amiodarone (also has Class I, II, IV properties)
  • Sotalol (also has Class II properties)
  • Dronedarone
  • Dofetilide
  • Ibutilide
  • Bretylium

Class IV — Calcium Channel Blockers (Non-dihydropyridines)

Block L-type Ca²⁺ channels → ↓ AV nodal conduction
  • Verapamil
  • Diltiazem

Unclassified / Miscellaneous Antiarrhythmics

These don't fit neatly into the Vaughan Williams system:
DrugMechanism / Use
AdenosineActivates K⁺ channels → transient AV block; used for SVT termination
DigoxinVagotonic effect → ↓ AV conduction; used in AF rate control
AtropineMuscarinic antagonist; used for symptomatic bradycardia
Magnesium sulfateUsed for Torsades de Pointes and refractory VF
IvabradineHCN channel blocker → ↓ sinus rate (no effect on AV conduction)

Key Points to Remember

  • Amiodarone is the most commonly used antiarrhythmic — it has properties of all 4 classes.
  • Sotalol = Class II + III effects (beta-blocker + K⁺ channel blocker).
  • Propafenone = Class Ic + weak Class II (beta-blocking) properties.
  • Class Ic drugs (Flecainide, Propafenone) are contraindicated post-MI due to the CAST trial findings (increased mortality).
  • Class III drugs can cause QT prolongation and risk of Torsades de Pointes.
(Source: Management of Patients With Ventricular Arrhythmias and Prevention of Sudden Cardiac Death, p. 19)
This is a shared conversation. Sign in to Orris to start your own chat.